NEI New Innovator Award (DP2 Clinical Trial Not Allowed)

US · IL National Institutes of Health – National Eye Institute (NEI) grant unknown #PAR-26-087

Summary

The National Eye Institute (NEI), part of NIH/HHS, is offering the New Innovator Award (DP2 mechanism) to support exceptionally creative early-stage investigators pursuing highly innovative research. Clinical trials are explicitly not allowed under this funding opportunity. The award is intended to fund unusually innovative, high-impact research in vision science and eye health. This is a forecasted opportunity with an anticipated open date of September 23, 2025.

What they want

Technical requirements

Clinical trials are not allowed under this funding opportunity
DP2 grant mechanism applies
Applicants must be early-stage investigators

How they evaluate

Submission: Grants.gov federal grants portal (PAR-26-087)

Risks & flags

Forecasted status only — key details such as award ceiling, eligibility criteria, and submission deadline are not yet published
Source state listed as IL but NEI is a federal agency; place of performance is unclear
Minimal description provided — scope, evaluation criteria, and deliverables cannot be verified from available text

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

NEI New Innovator Award (DP2 Clinical Tria…

$unknown

Onboard ↗